Embed presentation
Downloaded 260 times








The document discusses Metabical, a new weight loss drug, and provides recommendations around demand forecasting, packaging, pricing strategies, and profitability over the first five years. It suggests that demand forecasting should use a combination of two scenarios. A package size of four weeks is recommended to ensure results within three months without missed doses. Three pricing strategies are outlined between $75-150, recommending $125 for good market penetration, branding, and ROI. The impact of pricing on five-year profitability is also addressed.
Overview of Metabical's demand estimation, pricing, and packaging strategies.
Metabical is the only FDA approved drug for BMI<30 with fewer side effects, safer than OTC drugs.
Demand forecast based on a combination of different scenarios to analyze market potential.
Proposed package size for 4 weeks at $125, ensuring compliance and effectiveness in results.
Different pricing strategies evaluated: $75 (high penetration, low ROI), $125 (better ROI), $150 (low penetration).






